Pharmaceutical Drug Delivery Market Report 2026

Pharmaceutical Drug Delivery Market Overview

• Pharmaceutical Drug Delivery market size has reached to $1883.27 billion in 2025 • Expected to grow to $2612.78 billion in 2030 at a compound annual growth rate (CAGR) of 6.8% • Growth Driver: Rising Prevalence Of Chronic Diseases Fuels Pharmaceutical Drug Delivery Market Growth Addressing Treatment Challenges • Market Trend: Strategic Partnerships For Enhanced Brain Drug Delivery Innovations In Overcoming The Blood-Brain Barrier • North America was the largest region and fastest growing region.

What Is Covered Under Pharmaceutical Drug Delivery Market?

Pharmaceutical drug delivery refers to the process or method of administering a drug to an animal or human to achieve a therapeutic effect. It is a formulation or apparatus that allows a medicinal material to target its site of action while avoiding nontarget cells, organs, or tissues. The main types of pharmaceutical drug delivery routes of administration are oral, ocular, pulmonary, nasal, injectable, topical, and other routes. The oral route refers to the administration of a drug through the mouth, which is the most common route for drug administration due to its sustained and controlled delivery, ease of administration, and feasibility for solid dosage forms. The different pharmaceutical drug delivery applications include infectious diseases, cancer, cardiovascular diseases, diabetes, respiratory diseases, central nervous system disorders, autoimmune diseases, and other applications. The different end-users include hospitals, home care settings, ASC/Clinics, and other end users.

What Is The Pharmaceutical Drug Delivery Market Growth Forecast?

The pharmaceutical drug delivery market size is expected to see strong growth in the next few years. It will grow to $2612.78 billion in 2030 at a compound annual growth rate (CAGR) of 6.8%. The growth in the forecast period can be attributed to emergence of biologics and biosimilars, integration of digital monitoring devices, innovations in nanocarrier systems, growth in home care and remote treatments, increasing demand for patient-centric therapies. Major trends in the forecast period include targeted drug delivery systems, nanotechnology-based formulations, wearable drug delivery devices, personalized medicine solutions, minimally invasive delivery methods.

Global Pharmaceutical Drug Delivery Market Segmentation

1) By Route Of Administration: Oral, Ocular, Pulmonary, Nasal, Injectable, Topical, Other Routes 2) By Application: Infectious Diseases, Cancer, Cardiovascular Diseases, Diabetes, Respiratory Diseases, Central Nervous System Disorders, Autoimmune Diseases, Other Applications 3) By End-User: Hospitals, Home Care Settings, ASC Or Clinics, Other End Users Subsegments: 1) By Oral: Tablets, Capsules, Liquids, Powders 2) By Ocular: Eye Drops, Ocular Inserts, Ocular Implants 3) By Pulmonary: Metered-Dose Inhalers (MDIs), Dry Powder Inhalers (DPIs), Nebulizers 4) By Nasal: Nasal Sprays, Nasal Gels, Nasal Powders 5) By Injectable: Intravenous (IV) Injections, Intramuscular (IM) Injections, Subcutaneous (SC) Injections, Biologics And Biosimilars 6) By Topical: Creams, Ointments, Gels, Transdermal Patches 7) By Other Routes: Sublingual, Buccal, Rectal, Intranasal

What Is The Driver Of The Pharmaceutical Drug Delivery Market?

The growing prevalence of chronic diseases is expected to propel the growth of the pharmaceutical drug delivery market going forward. Prevalence of chronic diseases refers to the total number of existing cases of chronic diseases in a population at a specific time. Pharmaceutical drug delivery helps the patients suffering from chronic diseases by delivering a pharmaceutical drug to a specific part of the body to treat different diseases. For instance, in September 2023, according to the World Health Organization, a Switzerland-based specialized agency of the United Nations, there were 41 million deaths, which is 74% of those caused by non-communicable diseases (NCDs) or chronic diseases every year globally. There were 17.9 million deaths from cardiovascular diseases, 9.3 million deaths from cancer, 4.1 million deaths from chronic respiratory diseases, and 2.0 million deaths from diabetes. Therefore, the growing prevalence of chronic diseases is driving the pharmaceutical drug delivery industry growth.

Key Players In The Global Pharmaceutical Drug Delivery Market

Major companies operating in the pharmaceutical drug delivery market are 3M Company., AbbVie Inc., Amgen Inc., AstraZeneca plc, Bayer AG, Becton Dickinson And Company, C. H. Boehringer Sohn AG & Co. KG, Boston Scientific Corporation, Bristol-Myers Squibb Company, Consort Medical plc, Eli Lilly and Company, Emergent Biosolutions Inc., F. Hoffmann-La Roche AG, GlaxoSmithKline plc, Johnson & Johnson, Kite Pharma Inc., Merck & Co Inc., Nemera France SAS, Novartis AG, Pfizer Inc, Sanofi S. A., SHL Medical AG, Teva Pharmaceuticals Industries Ltd., West Pharmaceutical Services Inc., Aerogen Pharma Limited, AptarGroup Inc., Biocon Ltd., Catalent Inc., Evonik Industries AG, Inovio Pharmaceuticals Inc., Mylan NV, Sensile Medical Inc., Ypsomed Holding AG

Global Pharmaceutical Drug Delivery Market Trends and Insights

Major companies operating in the pharmaceutical drug delivery market are adopting a strategic partnership approach that seeks to find novel transport targets and shuttle molecules to improve medicine delivery to the brain. Strategic partnerships refer to a process in which companies leverage each other's strengths and resources to achieve mutual benefits and success. For instance, in September 2023, Cordance Medical, a US-based medical equipment manufacturer company, formed a strategic partnership with EXACT Therapeutics to make it easier to deliver drugs to the brain. This collaboration combines Cordance Medical's NeuroAccess platform, which can open the blood-brain barrier (BBB) without surgery, with EXACT Therapeutics' Acoustic Cluster Therapy (ACT) technology. This partnership aims to improve treatments for brain diseases like tumors and neurodegenerative disorders by making it easier for medicines to reach the brain. EXACT Therapeutics is a UK-based, clinical-stage biopharmaceutical company.

What Are Latest Mergers And Acquisitions In The Pharmaceutical Drug Delivery Market?

In February 2024, AbbVie, Inc., a US-based biopharmaceutical company, acquired ImmunoGen, Inc. for approximately $10.1 billion. Through this acquisition, AbbVie aims to strengthen its drug delivery capabilities in oncology by integrating ImmunoGen’s proprietary antibody-drug conjugate (ADC) platform, enabling precise delivery of cytotoxic drugs to cancer cells and expanding its portfolio of targeted cancer therapies. ImmunoGen, Inc. is a US-based biopharmaceutical company that provides targeted drug delivery solutions through antibody-drug conjugates (ADCs).

Regional Insights

North America was the largest region in the pharmaceutical drug delivery market in 2025. North America is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Pharmaceutical Drug Delivery Market?

The pharmaceutical drug delivery market includes revenues earned by entities by administering a pharmaceutical compound to achieve a therapeutic effect. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Pharmaceutical Drug Delivery Market Report 2026?

The pharmaceutical drug delivery market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the pharmaceutical drug delivery industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.